Search

Kimberly Chong

Examiner (ID: 8669, Phone: (571)272-3111 , Office: P/1674 )

Most Active Art Unit
1635
Art Unit(s)
1636, 1635, 1674
Total Applications
2007
Issued Applications
1153
Pending Applications
209
Abandoned Applications
674

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5649721 [patent_doc_number] => 20060135456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Methods and compositions for RNA interference' [patent_app_type] => utility [patent_app_number] => 10/997086 [patent_app_country] => US [patent_app_date] => 2004-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 67 [patent_figures_cnt] => 67 [patent_no_of_words] => 41276 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20060135456.pdf [firstpage_image] =>[orig_patent_app_number] => 10997086 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/997086
Methods and compositions for RNA interference Nov 22, 2004 Issued
Array ( [id] => 13696 [patent_doc_number] => 07807646 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-10-05 [patent_title] => 'SHIP-deficiency to increase megakaryocyte progenitor production' [patent_app_type] => utility [patent_app_number] => 10/904667 [patent_app_country] => US [patent_app_date] => 2004-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9726 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/807/07807646.pdf [firstpage_image] =>[orig_patent_app_number] => 10904667 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/904667
SHIP-deficiency to increase megakaryocyte progenitor production Nov 21, 2004 Issued
Array ( [id] => 7045528 [patent_doc_number] => 20050250123 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Reducing galectin-12 activity to reduce formation of adipocytes' [patent_app_type] => utility [patent_app_number] => 10/995793 [patent_app_country] => US [patent_app_date] => 2004-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 22615 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20050250123.pdf [firstpage_image] =>[orig_patent_app_number] => 10995793 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/995793
Reducing galectin-12 activity to reduce formation of adipocytes Nov 21, 2004 Abandoned
Array ( [id] => 5015785 [patent_doc_number] => 20070258993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => 'Dna-Carrier Conjugate' [patent_app_type] => utility [patent_app_number] => 10/579229 [patent_app_country] => US [patent_app_date] => 2004-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 13824 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20070258993.pdf [firstpage_image] =>[orig_patent_app_number] => 10579229 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/579229
Dna-Carrier Conjugate Nov 11, 2004 Abandoned
Array ( [id] => 6925947 [patent_doc_number] => 20050239202 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Methods and compositions for inhibiting the function of polynucleotide sequences' [patent_app_type] => utility [patent_app_number] => 10/977537 [patent_app_country] => US [patent_app_date] => 2004-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15204 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20050239202.pdf [firstpage_image] =>[orig_patent_app_number] => 10977537 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/977537
Methods and compositions for inhibiting the function of polynucleotide sequences Oct 28, 2004 Abandoned
Array ( [id] => 7075268 [patent_doc_number] => 20050148536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'Methods for treating and preventing insulin resistance and related disorders' [patent_app_type] => utility [patent_app_number] => 10/977116 [patent_app_country] => US [patent_app_date] => 2004-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 25439 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20050148536.pdf [firstpage_image] =>[orig_patent_app_number] => 10977116 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/977116
Methods for treating and preventing insulin resistance and related disorders Oct 28, 2004 Abandoned
Array ( [id] => 4471187 [patent_doc_number] => 07943755 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-17 [patent_title] => 'Neuron regeneration' [patent_app_type] => utility [patent_app_number] => 11/577663 [patent_app_country] => US [patent_app_date] => 2004-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 12678 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/943/07943755.pdf [firstpage_image] =>[orig_patent_app_number] => 11577663 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/577663
Neuron regeneration Oct 21, 2004 Issued
Array ( [id] => 217285 [patent_doc_number] => 07612195 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-03 [patent_title] => 'Retroviral vectors for delivery of interfering RNA' [patent_app_type] => utility [patent_app_number] => 10/574416 [patent_app_country] => US [patent_app_date] => 2004-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 7 [patent_no_of_words] => 7813 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/612/07612195.pdf [firstpage_image] =>[orig_patent_app_number] => 10574416 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/574416
Retroviral vectors for delivery of interfering RNA Oct 20, 2004 Issued
Array ( [id] => 5194380 [patent_doc_number] => 20070082864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-12 [patent_title] => 'Method for inducing a specific rnai activity in cells and nucleic acids for carrying out said method' [patent_app_type] => utility [patent_app_number] => 10/576390 [patent_app_country] => US [patent_app_date] => 2004-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2986 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20070082864.pdf [firstpage_image] =>[orig_patent_app_number] => 10576390 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/576390
Method for inducing a specific rnai activity in cells and nucleic acids for carrying out said method Oct 18, 2004 Abandoned
Array ( [id] => 7070088 [patent_doc_number] => 20050245473 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Proliferation- and differentiation-modulating agents and uses therefor' [patent_app_type] => utility [patent_app_number] => 10/967648 [patent_app_country] => US [patent_app_date] => 2004-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 27471 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20050245473.pdf [firstpage_image] =>[orig_patent_app_number] => 10967648 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/967648
Proliferation- and differentiation-modulating agents and uses therefor Oct 14, 2004 Abandoned
Array ( [id] => 4682812 [patent_doc_number] => 20080249038 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Bone Morphogenetic Protein (Bmp) 2A and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 10/575121 [patent_app_country] => US [patent_app_date] => 2004-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17270 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20080249038.pdf [firstpage_image] =>[orig_patent_app_number] => 10575121 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/575121
Bone Morphogenetic Protein (Bmp) 2A and Uses Thereof Oct 5, 2004 Abandoned
Array ( [id] => 6983849 [patent_doc_number] => 20050153919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Oligonucleotide compositions and methods for treating disease including inflammatory conditions' [patent_app_type] => utility [patent_app_number] => 10/953512 [patent_app_country] => US [patent_app_date] => 2004-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 19079 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20050153919.pdf [firstpage_image] =>[orig_patent_app_number] => 10953512 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/953512
Oligonucleotide compositions and methods for treating disease including inflammatory conditions Sep 28, 2004 Issued
Array ( [id] => 7010780 [patent_doc_number] => 20050064496 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Methods and compositions for inhibiting the function of polynucleotide sequences' [patent_app_type] => utility [patent_app_number] => 10/949845 [patent_app_country] => US [patent_app_date] => 2004-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15208 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20050064496.pdf [firstpage_image] =>[orig_patent_app_number] => 10949845 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/949845
Methods and compositions for inhibiting the function of polynucleotide sequences Sep 23, 2004 Abandoned
Array ( [id] => 7010773 [patent_doc_number] => 20050064489 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Engineered U6 and H1 promoters' [patent_app_type] => utility [patent_app_number] => 10/947035 [patent_app_country] => US [patent_app_date] => 2004-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5476 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20050064489.pdf [firstpage_image] =>[orig_patent_app_number] => 10947035 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/947035
Engineered U6 and H1 promoters Sep 21, 2004 Abandoned
Array ( [id] => 6983848 [patent_doc_number] => 20050153918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Methods and compositions relating to hnRNP A1, A1B, A2, and B1 nucleic acid molecules' [patent_app_type] => utility [patent_app_number] => 10/943441 [patent_app_country] => US [patent_app_date] => 2004-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 31673 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20050153918.pdf [firstpage_image] =>[orig_patent_app_number] => 10943441 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/943441
Methods and compositions relating to hnRNP A1, A1B, A2, and B1 nucleic acid molecules Sep 16, 2004 Abandoned
Array ( [id] => 7195863 [patent_doc_number] => 20050164234 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Methods of using mammalian RNase H and compositions thereof' [patent_app_type] => utility [patent_app_number] => 10/943194 [patent_app_country] => US [patent_app_date] => 2004-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 34437 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20050164234.pdf [firstpage_image] =>[orig_patent_app_number] => 10943194 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/943194
Methods of using mammalian RNase H and compositions thereof Sep 15, 2004 Abandoned
Array ( [id] => 5726830 [patent_doc_number] => 20060057590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'RNA probes' [patent_app_type] => utility [patent_app_number] => 10/940537 [patent_app_country] => US [patent_app_date] => 2004-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2661 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20060057590.pdf [firstpage_image] =>[orig_patent_app_number] => 10940537 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/940537
RNA probes Sep 13, 2004 Abandoned
Array ( [id] => 6990865 [patent_doc_number] => 20050089902 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Methods and compositions for siRNA expression' [patent_app_type] => utility [patent_app_number] => 10/932408 [patent_app_country] => US [patent_app_date] => 2004-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10342 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20050089902.pdf [firstpage_image] =>[orig_patent_app_number] => 10932408 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/932408
Methods and compositions for siRNA expression Aug 31, 2004 Abandoned
Array ( [id] => 7206022 [patent_doc_number] => 20050043220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Methods and compositions for treating macular degeneration' [patent_app_type] => utility [patent_app_number] => 10/928533 [patent_app_country] => US [patent_app_date] => 2004-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10557 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20050043220.pdf [firstpage_image] =>[orig_patent_app_number] => 10928533 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/928533
Methods and compositions for treating macular degeneration Aug 26, 2004 Abandoned
Array ( [id] => 6944718 [patent_doc_number] => 20050196767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-08 [patent_title] => 'RNA interference mediated inhibition of GRB2 associated binding protein (GAB2) gene expression using short interfering nucleic acis (siNA)' [patent_app_type] => utility [patent_app_number] => 10/923380 [patent_app_country] => US [patent_app_date] => 2004-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 65321 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20050196767.pdf [firstpage_image] =>[orig_patent_app_number] => 10923380 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/923380
RNA interference mediated inhibition of GRB2 associated binding protein (GAB2) gene expression using short interfering nucleic acis (siNA) Aug 19, 2004 Abandoned
Menu